Skip to main content
. 2018 Feb 20;154(1):69–75. doi: 10.1111/imm.12902

Figure 1.

Figure 1

Simplified sketch showing the mode of action of statins as immunosuppressive strategy. Statins inhibit the rate‐limiting enzyme of the mevalonate pathway leading to reduced levels of its downstream products. The pyrophosphate downstream products are critical for geranylgeranylation or farnesylation of GTPases that mediate multiple steps in the immune response such as cell migration, activation, signalling and cytokine production.